Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma

scientific article

Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1038437058
P356DOI10.1186/1471-2407-13-22
P8608Fatcat IDrelease_nvdqa2xb6zgc7nacq43qsfdn4u
P932PMC publication ID3722081
P698PubMed publication ID23324131
P5875ResearchGate publication ID234156751

P50authorLorenzo SpaggiariQ63437485
P2093author name stringCeccarelli Matteo
Ceribelli Anna
Crivellari Gino
DePas Tommaso Martino
Facciolo Francesco
Favaretto Adolfo
Kazeem Gbenga
Marchi Paolo
Marulli Giuseppe
Paccagnella Adriano
Rea Federico
Russo Francesca
Spaggiari Lorenzo
P2860cites workPhase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesotheliomaQ34214330
Advances in malignant mesotheliomaQ34459139
Malignant mesothelioma: options for managementQ35020407
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility studyQ35141809
Pemetrexed and malignant pleural mesotheliomaQ36522672
Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesotheliomaQ36822118
Future developments in the management of malignant pleural mesotheliomaQ37449036
Malignant pleural mesothelioma: current treatments and emerging drugs.Q37529848
Radiotherapy in malignant pleural mesotheliomaQ37593248
Multimodality strategies in malignant pleural mesotheliomaQ37613234
Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.Q43043845
The MARS feasibility trial: conclusions not supported by dataQ46905759
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesotheliomaQ80147152
P407language of work or nameEnglishQ1860
P921main subjectcisplatinQ412415
phase II clinical trialQ42824440
P304page(s)22
P577publication date2013-01-16
P1433published inBMC CancerQ326300
P1476titlePhase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma
P478volume13

Reverse relations

cites work (P2860)
Q58804842Adjuvant, neoadjuvant, and definitive radiation therapy for malignant pleural mesothelioma
Q60928995Biodistribution and Tumor Uptake of Ga-Nimotuzumab in a Malignant Pleural Mesothelioma Xenograft
Q59137556Combined modality treatment in mesothelioma: a systemic literature review with treatment recommendations
Q27908468Consensus report of the 2015 Weinman International Conference on Mesothelioma
Q64882003Defining the role of adjuvant radiotherapy for malignant pleural mesothelioma: a propensity-matched landmark analysis of the National Cancer Database.
Q64080942Extra-pleural pneumonectomy
Q34130373Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma
Q41262195Hemithoracic radiation therapy after extrapleural pneumonectomy for malignant pleural mesothelioma: Toxicity and outcomes at an Australian institution
Q38255347Local and systemic therapies for malignant pleural mesothelioma
Q36417109Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy
Q38215513Management of malignant pleural mesothelioma-The European experience
Q40354488Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial
Q50049398Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma
Q89889132Prolonged Progression-Free Survival in a Patient With Malignant Pleural Mesothelioma Following Korean Herbal Medicine Treatment Alone: A Case Report
Q64234040Prolonged post-recurrence survival following pleurectomy/decortication for malignant pleural mesothelioma
Q40223042Propensity matched comparison of extrapleural pneumonectomy and pleurectomy/decortication for mesothelioma patients†.
Q50200696Radiotherapy for the treatment of malignant pleural mesothelioma
Q40294287Relapse pattern and second-line treatment following multimodality treatment for malignant pleural mesothelioma
Q89390949Scientific Advances and New Frontiers in Mesothelioma Therapeutics
Q38195607Surgical management of malignant pleural mesothelioma: impact of surgery on survival and quality of life-relation to chemotherapy, radiotherapy, and alternative therapies.
Q89502927The Role of Neoadjuvant Chemotherapy in Patients with Resectable Malignant Pleural Mesothelioma - An Institutional and National Analysis
Q38599311The role of radical radiotherapy in the management of malignant pleural mesothelioma: A systematic review
Q37128016Which type of surgery should become the preferred procedure for malignant pleural mesothelioma: extrapleural pneumonectomy or extended pleurectomy?